Country
United Kingdom
City
Belfast
Headquarters
Belfast, Northern Ireland
Founded
2005
Industry
Pharmaceutical Manufacturing
Size
51 - 200
Specialties
Personalized medicine planning and corporate strategy, Comprehensive commercial planning in personalized medicine, Optimizing return on investment in personalized medicine, Leveraging diagnostics to enhance value in personalized medicine, Understanding the diagnostic landscape, Diagnostic development and commercialization service provision, Test implementation in treatment pathways, Driving better testing to enable better treatment decisions for patients
Total Rounds
2
Last Round
Tue Aug 25 2020
Last Round Series
Post IPO debt
Last Round Raised
$ 5,287,613
